The treatment paradigm for T2DM includes initial lifestyle changes to attempt to reduce insulin resistance often supplemented with oral metformin, a biguanide-class drug whose primary mechanism of action is to reduce hepatic glucose production while simultaneously increasing insulin uptake in insulin-sensitive tissues (6). This evidence concerns the gene INS and type 2 diabetes mellitus.